The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Engineering RNA for Targeted siRNA Delivery and Medical Application
Open accessAbstract
RNA engineering for nanotechnology and medical applications is an exciting emerging research field. RNA has intrinsically defined features on the nanometer scale and is a particularly interesting candidate for such applications due to its amazing diversity, flexibility and versatility in structure and function. Specifically, the current use of siRNA to silence target genes involved in disease has generated much excitement in the scientific community. The intrinsic ability to sequence-specifically down-regulate gene expression in a temporally- and spatially-controlled fashion has led to heightened interest and rapid development of siRNA-based therapeutics. Though methods for gene silencing with high efficacy and specificity have been achieved in vitro, the effective delivery of nucleic acids to specific cells in vivo has been a hurdle for RNA therapeutics. This review covers different RNA-based approaches for diagnosis, prevention and treatment of human disease, with a focus on the latest developments of nonviral carriers of siRNA for delivery in vivo. The applications and challenges of siRNA therapy, as well as potential solutions to these problems, the approaches for using phi29 pRNA-based vectors as polyvalent vehicles for specific delivery of siRNA, ribozymes, drugs or other therapeutic agents to specific cells for therapy will also be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
A Species of Small Antisense RNA in Posttranscriptional Gene Silencing in Plants
Hamilton, A. J., & Baulcombe, D. C. (1999) · Science · doi:10.1126/science.286.5441.950 · Cited by 3,041
The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme
Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., & Altman, S. (1983) · Cell · doi:10.1016/0092-8674(83)90117-4 · Cited by 2,684
Kruger, K., Grabowski, P. J., Zaug, A. J., Sands, J., Gottschling, D. E., & Cech, T. R. (1982) · Cell · doi:10.1016/0092-8674(82)90414-7 · Cited by 2,331
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
New Approaches to Nanofabrication: Molding, Printing, and Other Techniques
Gates, B. D., Xu, Q., Stewart, M., Ryan, D., Willson, C. G., & Whitesides, G. M. (2005) · Chemical Reviews · doi:10.1021/cr030076o · Cited by 2,020
On Finding All Suboptimal Foldings of an RNA Molecule
Zuker, M. (1989) · Science · doi:10.1126/science.2468181 · Cited by 2,005
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 2×
“5 mgkg, resulting in a 65% reduction of serumcholesterol [150].”
Single-crystal gallium nitride nanotubes
Goldberger, J., He, R., Zhang, Y., Lee, S., Yan, H., Choi, H.-J., & Yang, P. (2003) · Nature · doi:10.1038/nature01551 · Cited by 1,247
Mechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
RNAi therapeutics: a potential new class of pharmaceutical drugs
Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006) · Nature Chemical Biology · doi:10.1038/nchembio839 · Cited by 1,085
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Thin solid films roll up into nanotubes
Schmidt, O. G., & Eberl, K. (2001) · Nature · doi:10.1038/35065525 · Cited by 1,018
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
SELF-SPLICING OF GROUP I INTRONS
Cech, T. R. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.002551 · Cited by 888
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
siRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
Ellington, A. D., & Szostak, J. W. (1992) · Nature · doi:10.1038/355850a0 · Cited by 856
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Kam, N. W. S., Liu, Z., & Dai, H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053962k · Cited by 784
siRNA-directed inhibition of HIV-1 infection
Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S.-K., Collman, R. G., Lieberman, J., Shankar, P., & Sharp, P. A. (2002) · Nature Medicine · doi:10.1038/nm725 · Cited by 773
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
In vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Antisense RNA Inactivation of Myosin Heavy Chain Gene Expression in Dictyostelium discoideum
Knecht, D. A., & Loomis, W. F. (1987) · Science · doi:10.1126/science.3576221 · Cited by 676
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites
Forster, A. C., & Symons, R. H. (1987) · Cell · doi:10.1016/0092-8674(87)90562-9 · Cited by 666
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Ribozymes as Potential Anti-HIV-1 Therapeutic Agents
Sarver, N., Cantin, E. M., Chang, P. S., Zaia, J. A., Ladne, P. A., Stephens, D. A., & Rossi, J. J. (1990) · Science · doi:10.1126/science.2107573 · Cited by 658
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Monteys, A. M., Martins, I., Gilmore, B. L., Burstein, H., Peluso, R. W., Polisky, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801775105 · Cited by 607
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
In vivo activity of nuclease-resistant siRNAs
LAYZER, J. M., MCCAFFREY, A. P., TANNER, A. K., HUANG, Z., KAY, M. A., & SULLENGER, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 580
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
Vascular and interstitial barriers to delivery of therapeutic agents in tumors
Jain, R. K. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00046364 · Cited by 489
Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., & Kataoka, K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044941d · Cited by 476
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., & Eckstein, F. (1991) · Science · doi:10.1126/science.1857967 · Cited by 463
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Aptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
Kawasaki, A. M., Casper, M. D., Freier, S. M., Lesnik, E. A., Zounes, M. C., Cummins, L. L., Gonzalez, C., & Cook, P. D. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00059a007 · Cited by 438
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431
Glotzer, S. C. (2004) · Science · doi:10.1126/science.1099988 · Cited by 420
Functional Anatomy of a dsRNA Trigger
Parrish, S., Fleenor, J., Xu, S., Mello, C., & Fire, A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00106-4 · Cited by 400
MicroRNAs in Disease and Potential Therapeutic Applications
Soifer, H. S., Rossi, J. J., & Sætrom, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300311 · Cited by 394
Metals, Motifs, and Recognition in the Crystal Structure of a 5S rRNA Domain
Correll, C. C., Freeborn, B., Moore, P. B., & Steitz, T. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80457-2 · Cited by 392
Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase
Kim, D.-H., Longo, M., Han, Y., Lundberg, P., Cantin, E., & Rossi, J. J. (2004) · Nature Biotechnology · doi:10.1038/nbt940 · Cited by 382
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension
Baneyx, G., Baugh, L., & Vogel, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072650799 · Cited by 374
Thomas, M., Lu, J. J., Ge, Q., Zhang, C., Chen, J., & Klibanov, A. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502067102 · Cited by 366
Chawla-Sarkar, M., Bae, S. I., Reu, F. J., Jacobs, B. S., Lindner, D. J., & Borden, E. C. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401416 · Cited by 359
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., Hanai, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501753102 · Cited by 355
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y. J., Kim, S., Park, H.-O., & Choi, Y.-C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348
RNA interference and chemically modified small interfering RNAs
Manoharan, M. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.007 · Cited by 346
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.-P., & Unverzagt, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.018 · Cited by 338
Minakuchi, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh093 · Cited by 336
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Robbins, M., Judge, A., Liang, L., McClintock, K., Yaworski, E., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300240 · Cited by 336
A Small Viral RNA Is Required for in Vitro Packaging of Bacteriophage φ29 DNA
Guo, P., Erickson, S., & Anderson, D. (1987) · Science · doi:10.1126/science.3107124 · Cited by 312
Self-citationSuppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S., Kossen, K., Fosnaugh, K., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302641 · Cited by 307
Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy
Zhou, J., Li, H., Li, S., Zaia, J., & Rossi, J. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.92 · Cited by 301
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
pH-Sensitive liposomes-principle and application in cancer therapy
Karanth, H., & Murthy, R. S. R. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.4.0001 · Cited by 294
Autocatalytic cyclization of an excised intervening sequence RNA is a cleavage–ligation reaction
Zaug, A. J., Grabowski, P. J., & Cech, T. R. (1983) · Nature · doi:10.1038/301578a0 · Cited by 293
Chemical modification: the key to clinical application of RNA interference?
Corey, D. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33483 · Cited by 285
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Insights into the mechanism of magnetofection using PEI‐based magnetofectins for gene transfer
Huth, S., Lausier, J., Gersting, S. W., Rudolph, C., Plank, C., Welsch, U., & Rosenecker, J. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.577 · Cited by 280
All you wanted to know about SELEX
Klug, S. J., & Famulok, M. (1994) · Molecular Biology Reports · doi:10.1007/bf00996358 · Cited by 275
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 275
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Zhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R., & Rossi, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp185 · Cited by 267
Burkatovskaya, M., Tegos, G. P., Swietlik, E., Demidova, T. N., P Castano, A., & Hamblin, M. R. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.028 · Cited by 263
Perry, C. M., & Barman Balfour, J. A. (1999) · Drugs · doi:10.2165/00003495-199957030-00010 · Cited by 243
Li, M.-J., Kim, J., Li, S., Zaia, J., Yee, J.-K., Anderson, J., Akkina, R., & Rossi, J. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.524 · Cited by 241
Khaled, A., Guo, S., Li, F., & Guo, P. (2005) · Nano Letters · doi:10.1021/nl051264s · Cited by 233
Self-citationSong, E., Lee, S.-K., Dykxhoorn, D. M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P. A., Lieberman, J., Manjunath, N., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7174-7181.2003 · Cited by 230
Targeting survivin in cancer therapy: fulfilled promises and open questions
Pennati, M., Folini, M., & Zaffaroni, N. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm047 · Cited by 229
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe
Moore, A., Medarova, Z., Potthast, A., & Dai, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3230 · Cited by 226
Therapies for Alzheimer's disease
Melnikova, I. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2314 · Cited by 219
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
Zhang, C., Tang, N., Liu, X., Liang, W., Xu, W., & Torchilin, V. P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.022 · Cited by 210
The role of nanobiotechnology in drug discovery
Jain, K. K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03573-7 · Cited by 207
Tanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., & Kaneo, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.050 · Cited by 206
Guo, S., Tschammer, N., Mohammed, S., & Guo, P. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1097 · Cited by 195
Self-citationMaterializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology
Shu, D., Moll, W.-D., Deng, Z., Mao, C., & Guo, P. (2004) · Nano Letters · doi:10.1021/nl0494497 · Cited by 184
Self-citationEvaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo
Mook, O. R., Baas, F., de Wissel, M. B., & Fluiter, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0195 · Cited by 182
cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA
Prats, A. C., Roy, C., Wang, P. A., Erard, M., Housset, V, Gabus, C., Paoletti, C., & Darlix, J. L. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.774-783.1990 · Cited by 177
Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176
Ui-Tei, K., Naito, Y., Zenno, S., Nishi, K., Yamato, K., Takahashi, F., Juni, A., & Saigo, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn042 · Cited by 176
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 174
Evolutionary perspective on the structure and function of ribonuclease P, a ribozyme
Pace, N. R., & Brown, J. W. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.8.1919-1928.1995 · Cited by 173
Synthesis and Characterization of a Carbon Nanotube−Dendron Series for Efficient siRNA Delivery
Herrero, M. A., Toma, F. M., Al-Jamal, K. T., Kostarelos, K., Bianco, A., Da Ros, T., Bano, F., Casalis, L., Scoles, G., & Prato, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903316z · Cited by 168
RNA Nanotechnology: Engineering, Assembly and Applications in Detection, Gene Delivery and Therapy
Guo, P. (2005) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2005.446 · Cited by 161
Self-citationAdvances in magnetofection—magnetically guided nucleic acid delivery
Schillinger, U., Brill, T., Rudolph, C., Huth, S., Gersting, S., Krötz, F., Hirschberger, J., Bergemann, C., & Plank, C. (2005) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2005.01.032 · Cited by 158
Harland, R. M., & Misher, L. (1988) · Development · doi:10.1242/dev.102.4.837 · Cited by 143
Novel guanosine requirement for catalysis by the hairpin ribozyme
Chowrira, B. M., Berzal‐Herranz, A., & Burke, J. M. (1991) · Nature · doi:10.1038/354320a0 · Cited by 143
Wohlbold, L., van der Kuip, H., Miething, C., Vornlocher, H., Knabbe, C., Duyster, J., & Aulitzky, W. E. (2003) · Blood · doi:10.1182/blood-2002-12-3899 · Cited by 142
Functional Genomic Analysis of Apoptotic DNA Degradation in C. elegans
Parrish, J. Z., & Xue, D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00095-9 · Cited by 140
Synthetic antibodies for specific recognition and crystallization of structured RNA
Ye, J., Tereshko, V. A., Frederiksen, J. K., Koide, A., Fellouse, F. A., Sidhu, S. S., Koide, S., Kossiakoff, A. A., & Piccirilli, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709082105 · Cited by 132
Enhancing and targeting nucleic acid delivery by magnetic force
Plank, C., Anton, M., Rudolph, C., Rosenecker, J., & Krötz, F. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.5.745 · Cited by 127
Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies
Pirollo, K. F., & Chang, E. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5810 · Cited by 121
Iyer, A. K., Greish, K. F., Seki, T., Okazaki, S., Fang, J. Q., Takeshita, K., & Maeda, H. (2007) · Journal of drug targeting · doi:10.1080/10611860701498252 · Cited by 116
The hammerhead RNA domain, a model ribozyme
Bratty, J., Chartrand, P., Ferbeyre, G., & Cedergren, R. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90001-t · Cited by 102
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer
Ai, Z., Yin, L., Zhou, X., Zhu, Y., Zhu, D., Yu, Y., & Feng, Y. (2006) · Cancer · doi:10.1002/cncr.22044 · Cited by 101
Chang, L.-J., Liu, X., & He, J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302509 · Cited by 99
In vivo RNA Interference–Mediated Ablation of MDR1 P-Glycoprotein
Pichler, A., Zelcer, N., Prior, J. L., Kuil, A., & Piwnica-Worms, D. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0038 · Cited by 97
Anderson, J. S., & Akkina, R. (2005) · AIDS Research and Therapy · doi:10.1186/1742-6405-2-1 · Cited by 95
Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy
Kim, W. J., Chang, C., Lee, M., & Kim, S. W. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.026 · Cited by 95
The silent treatment: RNAi as a defense against virus infection in mammals
van Rij, R. P., & Andino, R. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.02.006 · Cited by 91
Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus
Hoeprich, S., Zhou, Q., Guo, S., Shu, D., Qi, G., Wang, Y., & Guo, P. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302002 · Cited by 91
Self-citationCutting Edge: Novel RNA Ligands Able to Bind CD4 Antigen and Inhibit CD4+ T Lymphocyte Function
Kraus, E., James, W., & Barclay, A. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5209 · Cited by 90
Mcgookey, D., Fagerberg, K., & Anderson, R. G. W. (1983) · Journal of Cell Biology · doi:10.1083/jcb.96.5.1273 · Cited by 86
DETERMINATION OF RNA STRUCTURE AND THERMODYNAMICS
Jaeger, J. A., SantaLucia, J., & Tinoco, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.001351 · Cited by 83
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin
Yonesaka, K., Tamura, K., Kurata, T., Satoh, T., Ikeda, M., Fukuoka, M., & Nakagawa, K. (2005) · International Journal of Cancer · doi:10.1002/ijc.21350 · Cited by 76
Kim, E., Jeong, H., Park, I., Cho, C., Moon, H., Yu, D., Bom, H., Sohn, M., & Oh, I.-J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.001 · Cited by 70
TectoRNA and ‘kissing‐loop’ RNA: atomic force microscopy of self‐assembling RNA structures
Hansma, H. G., Oroudjev, E., Baudrey, S., & Jaeger, L. (2003) · Journal of Microscopy · doi:10.1111/j.1365-2818.2003.01276.x · Cited by 69
Kinouchi, N., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanimoto, Y., Moriyama, K., & Noji, S. (2008) · Gene Therapy · doi:10.1038/gt.2008.24 · Cited by 68
[21] RNA pseudoknot: Structure, detection, and prediction
Pleij, C. W. A., & Bosch, L. V. D. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)80107-7 · Cited by 64
Phosphorothioate‐stimulated uptake of short interfering RNA by human cells
Overhoff, M. G., & Sczakiel, G. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400535 · Cited by 58
Lewis, D. L., & Wolff, J. A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)92020-4 · Cited by 56
The Hairpin Ribozyme: Discovery, Two-Dimensional Model, and Development for Gene Therapy
HAMPEL, A. E. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60032-x · Cited by 56
Specificities involved in the initiation of retroviral plus-strand DNA
Luo, G. G., Sharmeen, L., & Taylor, J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.592-597.1990 · Cited by 56
Structure and function of φ29 hexameric RNA that drives the viral DNA packaging motor: Review
Guo, P. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72076-x · Cited by 54
Self-citationA Viral RNA That Binds ATP and Contains a Motif Similar to an ATP-binding Aptamer from SELEX
Shu, D., & Guo, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209895200 · Cited by 51
Self-citationViel, T., Boisgard, R., Kühnast, B., Jégo, B., Siquier-Pernet, K., Hinnen, F., Dollé, F., & Tavitian, B. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0133 · Cited by 49
Liu, H., Guo, S., Roll, R. L., Li, J., Diao, Z., Shao, N., Riley, M. R., Cole, A. M., Robinson, J. P., Snead, N. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.3962 · Cited by 48
Self-citationYokota, T., Miyagishi, M., Hino, T., Matsumura, R., Tasinato, A., Urushitani, M., Rao, R. V., Takahashi, R., Bredesen, D. E., Taira, K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.098 · Cited by 47
Melnikova, I. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2443 · Cited by 46
Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs
Zhang, H. M., Su, Y., Guo, S., Ji, Y., Lim, T. W., Liu, J., Guo, P., & Yang, D. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.07.005 · Cited by 43
Self-citationIn vitro selection methodologies to probe RNA function and structure
Conrad, R. C., Baskerville, S., & Ellington, A. D. (1995) · Molecular Diversity · doi:10.1007/bf01715810 · Cited by 41
Transporting silence: Design of carriers for siRNA to angiogenic endothelium
Schiffelers, R. M., Mixson, A. J., Ansari, A. M., Fens, M. H. A. M., Tang, Q., Zhou, Q., Xu, J., Molema, G., Lu, P. Y., Scaria, P. V., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.018 · Cited by 41
Melnikova, I. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2511 · Cited by 40
Nanomedicine and Drug Delivery
Wei, C., Wei, W., Morris, M. A., Kondo, E., Gorbounov, M., & Tomalia, D. A. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.05.005 · Cited by 39
Design of protein struts for self-assembling nanoconstructs
Hyman, P., Valluzzi, R., & Goldberg, E. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132544299 · Cited by 38
Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions
Zhang, K., Wang, Q., Xie, Y., Mor, G., Sega, E. I., Low, P. S., & Huang, Y. (2008) · RNA · doi:10.1261/rna.739308 · Cited by 37
bcl‐2‐specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cells
Okamoto, K., Ocker, M., Neureiter, D., Dietze, O., Zopf, S., Hahn, E. G., & Herold, C. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00013.x · Cited by 35
Mechanism of Dimerization of Bicoid mRNA
Wagner, C., Ehresmann, C., Ehresmann, B., & Brunel, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306511200 · Cited by 35
Kashani‐Sabet, M. (2002) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2002.19642.x · Cited by 34
Hough, S. R., Wiederholt, K. A., Burrier, A. C., Woolf, T. M., & Taylor, M. F. (2003) · Nature Biotechnology · doi:10.1038/nbt0703-731b · Cited by 32
Guo, P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-858-7:285 · Cited by 30
Self-citationStessl, M., Marchetti‐Deschmann, M., Winkler, J., Lachmann, B., Allmaier, G. M., & Noe, C. R. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.06.001 · Cited by 29
Chiu, J., Lee, P.-L., Chang, S., Chen, L.-J., Lee, C.-I., Lin, K. M.-C., Usami, S., & Chien, S. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-4338-4 · Cited by 25
Method to Silence Genes Earns Loud Praise
Couzin, J. (2006) · Science · doi:10.1126/science.314.5796.34 · Cited by 24
Rusckowski, M., QU, T., Roskey, A., & Agrawal, S. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.333 · Cited by 20
Kanda, T., Yokosuka, O., Imazeki, F., Arai, M., & Saisho, H. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.805 · Cited by 19
Ravikumar, V. T., Andrade, M., Carty, R. L., Dan, A., & Barone, S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.081 · Cited by 11
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Aptamer in Bioanalytical Applications
Iliuk, A. B., Hu, L., & Tao, W. A. (2011) · Analytical Chemistry · doi:10.1021/ac201057w · Cited by 762
Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., & Petri-Fink, A. (2012) · Chemical Reviews · doi:10.1021/cr2002596 · Cited by 617
Macrophages as a therapeutic target to promote diabetic wound healing
Sharifiaghdam, M., Shaabani, E., Faridi-Majidi, R., De Smedt, S. C., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.016 · Cited by 573
Exosome mimetics: a novel class of drug delivery systems
Schiffelers, R., Kooijmans, S., Vader, van Dommelen, & Solinge, V. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29661 · Cited by 512
Metadata
- Authors
- Guo, P., Coban, O., Snead, N. M., Trebley, J., Hoeprich, S., Guo, S., & Shu, Y.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 62
- Issue
- 6
- Pages
- 650-666
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2066319460
- Cited by
- 300
- References
- 172
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.